Silverfin false false 30/06/2024 01/07/2023 30/06/2024 Professor S Bahn 01/08/2005 11 October 2024 The principal activity of the Company during the financial year was research and experimental development in biotechnology. 05524107 2024-06-30 05524107 bus:Director1 2024-06-30 05524107 2023-06-30 05524107 core:CurrentFinancialInstruments 2024-06-30 05524107 core:CurrentFinancialInstruments 2023-06-30 05524107 core:Non-currentFinancialInstruments 2024-06-30 05524107 core:Non-currentFinancialInstruments 2023-06-30 05524107 core:ShareCapital 2024-06-30 05524107 core:ShareCapital 2023-06-30 05524107 core:SharePremium 2024-06-30 05524107 core:SharePremium 2023-06-30 05524107 core:RetainedEarningsAccumulatedLosses 2024-06-30 05524107 core:RetainedEarningsAccumulatedLosses 2023-06-30 05524107 core:PlantMachinery 2023-06-30 05524107 core:OfficeEquipment 2023-06-30 05524107 core:PlantMachinery 2024-06-30 05524107 core:OfficeEquipment 2024-06-30 05524107 bus:OrdinaryShareClass1 2024-06-30 05524107 bus:PreferenceShareClass1 2024-06-30 05524107 2023-07-01 2024-06-30 05524107 bus:FilletedAccounts 2023-07-01 2024-06-30 05524107 bus:SmallEntities 2023-07-01 2024-06-30 05524107 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 05524107 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 05524107 bus:Director1 2023-07-01 2024-06-30 05524107 core:PlantMachinery core:TopRangeValue 2023-07-01 2024-06-30 05524107 core:OfficeEquipment core:TopRangeValue 2023-07-01 2024-06-30 05524107 2022-07-01 2023-06-30 05524107 core:PlantMachinery 2023-07-01 2024-06-30 05524107 core:OfficeEquipment 2023-07-01 2024-06-30 05524107 bus:OrdinaryShareClass1 2023-07-01 2024-06-30 05524107 bus:OrdinaryShareClass1 2022-07-01 2023-06-30 05524107 bus:PreferenceShareClass1 2023-07-01 2024-06-30 05524107 bus:PreferenceShareClass1 2022-07-01 2023-06-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 05524107 (England and Wales)

PSYNOVA NEUROTECH LIMITED

Unaudited Financial Statements
For the financial year ended 30 June 2024
Pages for filing with the registrar

PSYNOVA NEUROTECH LIMITED

Unaudited Financial Statements

For the financial year ended 30 June 2024

Contents

PSYNOVA NEUROTECH LIMITED

STATEMENT OF FINANCIAL POSITION

As at 30 June 2024
PSYNOVA NEUROTECH LIMITED

STATEMENT OF FINANCIAL POSITION (continued)

As at 30 June 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 3 1,031 2,148
1,031 2,148
Current assets
Debtors
- due within one year 4 16,810 20,274
- due after more than one year 4 121,250 118,928
Cash at bank and in hand 382,651 357,218
520,711 496,420
Creditors: amounts falling due within one year 5 ( 37,628) ( 31,352)
Net current assets 483,083 465,068
Total assets less current liabilities 484,114 467,216
Net assets 484,114 467,216
Capital and reserves
Called-up share capital 6 7,345 7,345
Share premium account 4,621,497 4,621,497
Profit and loss account ( 4,144,728 ) ( 4,161,626 )
Total shareholder's funds 484,114 467,216

For the financial year ending 30 June 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The financial statements of Psynova Neurotech Limited (registered number: 05524107) were approved and authorised for issue by the Director on 11 October 2024. They were signed on its behalf by:

Professor S Bahn
Director
PSYNOVA NEUROTECH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 June 2024
PSYNOVA NEUROTECH LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 June 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Psynova Neurotech Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is St John's Innovation Centre, Cowley Road, Cambridge, CB4 0WS, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The director has assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Statement of Financial Position date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended. Depreciation is provided on all tangible fixed assets, other than investment properties and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line basis over its expected useful life, as follows:

Plant and machinery 6.7 years straight line
Office equipment 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Statement of Financial Position date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including the director 1 1

3. Tangible assets

Plant and machinery Office equipment Total
£ £ £
Cost
At 01 July 2023 595 3,424 4,019
At 30 June 2024 595 3,424 4,019
Accumulated depreciation
At 01 July 2023 356 1,515 1,871
Charge for the financial year 89 1,028 1,117
At 30 June 2024 445 2,543 2,988
Net book value
At 30 June 2024 150 881 1,031
At 30 June 2023 239 1,909 2,148

4. Debtors

2024 2023
£ £
Debtors: amounts falling due within one year
Trade debtors 0 19,500
Prepayments 0 275
Other debtors 16,810 499
16,810 20,274
Debtors: amounts falling due after more than one year
Other debtors 121,250 118,928

5. Creditors: amounts falling due within one year

2024 2023
£ £
Trade creditors 30,635 21,008
Amounts owed to director 331 331
Accruals 2,952 2,476
Taxation and social security 3,427 7,537
Other creditors 283 0
37,628 31,352

6. Called-up share capital

2024 2023
£ £
Allotted, called-up and fully-paid
13,096,580 Ordinary shares of £ 0.0001 each (2023: 13,096,500 shares of £ 0.0001 each) 1,310 1,310
60,354,111 Preference shares of £ 0.0001 each 6,035 6,035
7,345 7,345

7. Related party transactions

Transactions with the entity's director

2024 2023
£ £
Amount owed to director 331 331

The loan is interest free and repayable on demand.